Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition.
about
The Role of Interaction Model in Simulation of Drug Interactions and QT ProlongationA novel genetic modifier for clarithromycin-related cardiac arrhythmia risk?Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias.A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm.Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration.Regulation of Kv4.3 and hERG potassium channels by KChIP2 isoforms and DPP6 and response to the dual K+ channel activator NS3623.
P2860
Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Modification by KCNE1 variants ...... to pharmacological inhibition.
@en
Modification by KCNE1 variants ...... to pharmacological inhibition.
@nl
type
label
Modification by KCNE1 variants ...... to pharmacological inhibition.
@en
Modification by KCNE1 variants ...... to pharmacological inhibition.
@nl
prefLabel
Modification by KCNE1 variants ...... to pharmacological inhibition.
@en
Modification by KCNE1 variants ...... to pharmacological inhibition.
@nl
P2093
P2860
P356
P1476
Modification by KCNE1 variants ...... to pharmacological inhibition.
@en
P2093
Aziza El Harchi
Chunyun Du
Henggui Zhang
Jules C Hancox
P2860
P304
P356
10.1002/PHY2.175
P577
2013-11-29T00:00:00Z